Luminogenic and nonluminogenic multiplex assay

Details Luminogenic and nonluminogenic multiplex assay Luminogenic and nonluminogenic multiplex assay

2006-07-20

2009-06-30

Weber, Jon P (Department: 1657)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving hydrolase

C435S029000, C435S007720

Reexamination Certificate

active

07553632

ABSTRACT:
A method to detect the presence or amount of at least one molecule for an enzyme-mediated reaction in a multiplex luminogenic
onluminogenic assay is provided.

REFERENCES:
patent: 5035999 (1991-07-01), Geiger et al.
patent: 5098828 (1992-03-01), Geiger et al.
patent: 5314805 (1994-05-01), Haugland et al.
patent: 5698411 (1997-12-01), Lucas et al.
patent: 5744320 (1998-04-01), Sherf et al.
patent: 5976822 (1999-11-01), Landrum et al.
patent: 6335429 (2002-01-01), Cai et al.
patent: 6586196 (2003-07-01), Bronstein et al.
patent: 6602657 (2003-08-01), Bronstein et al.
patent: 6613541 (2003-09-01), Vaddi et al.
patent: 6759207 (2004-07-01), Weber et al.
patent: 6811990 (2004-11-01), Corey et al.
patent: 6890745 (2005-05-01), Leng
patent: 7416854 (2008-08-01), Riss et al.
patent: 2002/0068316 (2002-06-01), Rust et al.
patent: 2002/0119500 (2002-08-01), Xue et al.
patent: 2003/0211560 (2003-11-01), O'Brien et al.
patent: 2004/0171099 (2004-09-01), Cali et al.
patent: 2005/0164321 (2005-07-01), Riss et al.
patent: 2008/0268482 (2008-10-01), Riss et al.
patent: 2009/0017482 (2009-01-01), Riss et al.
patent: 1382691 (2004-01-01), None
patent: WO-0036098 (2000-06-01), None
patent: WO-0050630 (2000-08-01), None
patent: WO-01/46694 (2001-06-01), None
patent: WO-0157242 (2001-08-01), None
patent: WO-0200882 (2002-01-01), None
patent: WO-0212547 (2002-02-01), None
patent: WO-03025192 (2003-03-01), None
patent: WO-03066611 (2003-08-01), None
patent: WO-2005073722 (2005-08-01), None
patent: WO-2005073722 (2005-08-01), None
patent: WO-2007027653 (2007-03-01), None
O'Connell et al. Live/Dead Assay for Cell Viability; AfCS Procedure Protocol PP00000023 (2002) http://wwwsignaling-gateway.org/data/cgi-bin/ProtocolFile.cgi/afcs—PP00000023.pdf?pid=PP00000023 downloaded Nov. 19, 2007.
Rosser et al. Calpain Activity Increases in Hepatocytes Following Addition of ATP; The Journal of Biological Chemistry, vol. 268, No. 31 (1993) pp. 23593-23600.
“Partial International Search Report for corresponding PCT Application No. PCT/US2005/002158”, (Oct. 12, 2006), 2 pgs.
Grant, S. K., et al., “Development of Novel Assays for Proteolytic Enzymes Using Rhodamine-Based Fluorogenic Substrates”,Journal of Biomolecular Screening, 7(6), (2002), 531-540.
“Apoptosis Inducers And The Assay of Caspase Activity Biomol”,Fased Journal, 2(8), Abstract No. T10, Federation of American Studies for Experimental Biology,(Apr. 24, 1998),p. A1488.
“U.S. Appl. No. 10/762,836, Response filed Nov. 2, 2006 Non-Final Office Action mailed Sep. 8, 2006”, 15 pgs.
“U.S. Appl. No. 10/762,836 RCE/Preliminary Amendment Filed on Aug. 31, 2007”, 10.
“U.S. Appl. No. 10/762,836, Final Office Action mailed Feb. 2, 2007”, 8 pgs.
“U.S. Appl. No. 10/762,836, Non-Final Office Action mailed Mar. 21, 2006”, 16 pgs.
“U.S. Appl. No. 10/762,836, Non-Final Office Action mailed Sep. 8, 2006”, 8 pgs.
“U.S. Appl. No. 10/762,836, Notice of allowance mailed May 31, 2007”, 6 pgs.
“U.S. Appl. No. 10/762,836, Response filed Apr. 2, 2007 Final Office Action mailed Feb. 2, 2007”, 24 pgs.
“U.S. Appl. No. 10/762,836, Response filed Jun. 21, 2006 Non-Final Office Action mailed Mar. 21, 2006”, 23 pgs.
“International Search Report mailed Jun. 14, 2007 in corresponding PCT Application No. PCT/US2005/002158”, 8 pgs.
“Written Opinion of the International Searching Authority mailed Jun. 14, 2007 in corresponding PCT Application No. PCT/US2005/002158”, 8 pgs.
Adrain, C. , et al., “Apoptosis-Associated Release of Smac/DIABLO From Mitochondria Requires Active Caspases and is Blocked by Bcl-2”,The EMBO Journal, 20(23), (2001),6627-6636.
Berkers, C. R., et al., “Activity Probe for in vivo Profiling of the Specificity of Proteasome Inhibitor Bortezomib”,Nature Methods, 2(5), (2005),357-362.
Fernandez, Y. , et al., “Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic Implications”,Cancer Research, 65(14), (2005),6294-6304.
Karlsson, J. O., et al., “Proteolytic Activity in Intact Sheets of Polarized Epithelial Cells as Determined by a Cell-Permeable Fluorogenic Substrate”,Cell Biology International,24(4), (2000),235-243.
Kisselev, A. F., et al., “Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies With Protein Substrate”,The Journal of Biological Chemistry, 281(13), (Mar. 31, 2006),8582-8590.
Kisselev, A. F., et al., “Monitoring Activity and Inhibition of 26S Proteasomes With Fluorogenic Peptide Substrates”,Methods in Enzymology, vol. 398, (2005),364-378.
Luker, G. D., et al., “Imaging 26S Proteasome Activity and Inhibition in Living Mice”,Nature Medicine, 9(7), (2003),969-973.
Monsees, T. , et al., “A Novel Bioluminogenic Assay for Alpha-Chymotrysin”,Journal of Bioluminescence And Chemiluninescence, 10(4), (Jul. 1995),213-218.
Ramsby, M. L., “Differential Detergent Fractionation of Isolated Hepatocytes: Biochemical, Immunochemical and Two-Dimensional Gel Electrophoresis Characterization of Cytoskeletal and Noncytoskeletal Compartments”,Electrophoresis, 15, (1994),265-277.
Wilkinson, J. C., et al., “Upstream Regulatory Role for XIAP in Receptor-Mediated Apoptosis”,Molecular and Cellular Biology, 24(16), (2004),7003-7014.
“Apoptosis: Annexin V & Propidium Iodide—Freedom to Discover”,Acumen Bioscience Ltd., (Prior to Jan. 20, 2004),2 pgs.
“Beadlyte (r) Multiplex Assay Systems”,Product Guide, Upstate Cell Signalling Solutions, (2002),12 pgs.
“Caspase-Glo tm 3/7 Assay”,Technical Bulletin No. 323, Promega Corporation, (May 2003),13 pgs.
“Cell Cytotoxicity—Freedom to Discover”,Acumen Bioscience Ltd., (Prior to Jan. 20, 2004),2 pgs.
“Cell Proliferation—Freedom to Discover”,Acumen Bioscience Ltd., (Prior to Jan. 22, 2004),2 pgs.
“CellTiter-Blue tm Cell Viability Assay”,Technical Bulletin No. 317, Promega Corporation, (Dec. 2002),12 pgs.
“CellTiter-Glo tm Luminescent Cell Viability Assay”,Technical Bullentin No. 288, Promega Corporation, (May 2001),11 pgs.
“CytoTox-One tm Homogeneous Membrane Integrity Assay”,Technical Bulletin No. 306, Promega Corporation, (May 2003),13 pgs.
“Dual-Light (r) Luminescent Report Gene Assay for Luciferase and Beta-Galactosidase”,Data Sheet, Applied Biosystems, (2000),2 pgs.
“Multiplex Antibody Kits Custom Software & Hardware for Luminex tm”,MiraiBio Inc., (Prior to Jan. 20, 2004)),2 pgs.
Bronstein, I. , et al., “Combined Luminescent Assays for Multiple Enzymes”,Bioluminescence and and Chemiluminescence: Molecular Reporting With Photons, (International Symposium Proceedings),(1997),451-457.
Damour, Marc , et al., “Non-Radioactive Multiplex Kinase Activity Assay Using Beadlyte (r) Suspension Microarrays”, (Prior to Jan. 20, 2004),1 pg.
De Jager, Wilco , et al., “Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells”,Clinical and Diagnostic Laboratory Immunology, 10(1), (2003), 133-139.
Dyer, Benjamin , et al., “A Noncommercial Dual Luciferase Enzyme Assay System for Report Gene Analysis”,Analytical Biochemistry, 282, (2000),158-161.
Farfan, Abigail , et al., “Frequently Asked Questions Cytotox-One tm Homogeneous Membrane Integrity Assay”,Cell Notes, Issue 6, (2003),19-20.
Gurtu, V. , et al., “Fluorometric and Colorimetric Detection of Caspase-Activity Associated with Apoptosis”,Analytical Biochemistry, 251, (1997),98-102.
Liu, Jingxue , et al., “Visualizing and Quantifying Protein Secretion Using a Renilla Luciferase-GFP Fusion Protein”,Luminescence, 15, (2000),45-49.
Mandlekar, S. , et al., “Activation of C

Affiliated with

Also associated with

Rating

Luminogenic and nonluminogenic multiplex assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Luminogenic and nonluminogenic multiplex assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Luminogenic and nonluminogenic multiplex assay will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4109689